| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |